JP2012525121A5 - - Google Patents

Download PDF

Info

Publication number
JP2012525121A5
JP2012525121A5 JP2012507624A JP2012507624A JP2012525121A5 JP 2012525121 A5 JP2012525121 A5 JP 2012525121A5 JP 2012507624 A JP2012507624 A JP 2012507624A JP 2012507624 A JP2012507624 A JP 2012507624A JP 2012525121 A5 JP2012525121 A5 JP 2012525121A5
Authority
JP
Japan
Prior art keywords
nucleic acid
tumor
associated antigen
antibody
agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2012507624A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012525121A (ja
Filing date
Publication date
Priority claimed from EP09005931A external-priority patent/EP2249159A1/en
Application filed filed Critical
Publication of JP2012525121A publication Critical patent/JP2012525121A/ja
Publication of JP2012525121A5 publication Critical patent/JP2012525121A5/ja
Pending legal-status Critical Current

Links

JP2012507624A 2009-04-29 2010-04-22 診断および治療のための腫瘍関連マーカーの同定 Pending JP2012525121A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US17387109P 2009-04-29 2009-04-29
US61/173,871 2009-04-29
EP09005931A EP2249159A1 (en) 2009-04-29 2009-04-29 Identification of tumor-associated markers for diagnosis and therapy
EP09005931.2 2009-04-29
PCT/EP2010/002490 WO2010124812A2 (en) 2009-04-29 2010-04-22 Identification of tumor-associated markers for diagnosis and therapy

Publications (2)

Publication Number Publication Date
JP2012525121A JP2012525121A (ja) 2012-10-22
JP2012525121A5 true JP2012525121A5 (https=) 2013-05-30

Family

ID=41100608

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012507624A Pending JP2012525121A (ja) 2009-04-29 2010-04-22 診断および治療のための腫瘍関連マーカーの同定

Country Status (6)

Country Link
US (1) US20120070430A1 (https=)
EP (2) EP2249159A1 (https=)
JP (1) JP2012525121A (https=)
AU (1) AU2010243863A1 (https=)
CA (1) CA2760395A1 (https=)
WO (1) WO2010124812A2 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2562721A (en) * 2017-05-16 2018-11-28 Fastbase Solutions Ltd Kits, methods and their uses for detecting cell-cell interactions in a sample
WO2023244744A2 (en) * 2022-06-15 2023-12-21 Nonexomics, Inc. Compositions and methods for treatment of cancer

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9019812D0 (en) 1990-09-11 1990-10-24 Scotgen Ltd Novel antibodies for treatment and prevention of infection in animals and man
US5677139A (en) 1995-04-21 1997-10-14 President And Fellows Of Harvard College In vitro differentiation of CD34+ progenitor cells into T lymphocytes
UA56132C2 (uk) 1995-04-25 2003-05-15 Смітклайн Бічем Байолоджікалс С.А. Композиція вакцини (варіанти), спосіб стабілізації qs21 відносно гідролізу (варіанти), спосіб приготування композиції вакцини
US20070042392A1 (en) * 2000-02-03 2007-02-22 Nuvelo, Inc. Novel nucleic acids and polypeptides
PT1309726E (pt) 2000-03-30 2010-03-08 Whitehead Biomedical Inst Mediadores de interferência por rna específicos de sequência de rna
JP2006517788A (ja) * 2002-12-20 2006-08-03 ミレニアム・ファーマシューティカルズ・インコーポレイテッド １５９８６、２１８８、２０７４３、９１４８、９１５１、９７９１、４４２５２、１４１８４、４２４６１、８２０４、７９７０、２５５５２、２１６５７、２６４９２、２４１１、１５０８８、１９０５、２８８９９、６３３８０、３３９３５、１０４８０、１２６８６、２５５０１、１７６９４、１５７０１、５３０６２、４９９０８、２１６１２、３８９４９、６２１６、４６８６３、９２３５、２２０１、６９８５、９８８３、１２２３８、１８０５７、２１６１７、３９２２８、４９９２８、５４４７６、６２１１３、６４３１６、１２２６４、３２３６２、５８１９８、２８８７、３２０５、８５５７、９６００、９６９３、４４８６７、５３０５８、５５５５６、５７６５８、２２０８、１０２５２、１０３０２、１４２１８、３３８７７、１０３１７、１０４８５、２５９６４、１４８１５、１３６３、１３９７、１４８２７、２１７０８、３８０１、６４６９８、２１７９または１３２４９を使用する癌を処置するための方法および組成物
DE102005013846A1 (de) * 2005-03-24 2006-10-05 Ganymed Pharmaceuticals Ag Identifizierung von Oberflächen-assoziierten Antigenen für die Tumordiagnose und -therapie
US20070231822A1 (en) * 2006-02-28 2007-10-04 Michael Mitas Methods for the detection and treatment of cancer
CA2745961A1 (en) * 2008-12-04 2010-06-10 The Regents Of The University Of California Materials and methods for determining diagnosis and prognosis of prostate cancer

Similar Documents

Publication Publication Date Title
US12235270B2 (en) Depleting tumor-specific tregs
JP2007537197A5 (https=)
ES2583754T3 (es) Productos génicos expresados de manera diferencial en tumores y utilización de los mismos
JP2010047597A5 (https=)
ES2664386T3 (es) Identificación de antígenos asociados a tumor para el diagnóstico y la terapia
JP2007506417A5 (https=)
JP2008537546A5 (https=)
JP2006516190A5 (https=)
JP2010063458A5 (https=)
CN105349618B (zh) 三阴性乳腺癌标记物及其在诊断和治疗中的应用
JP2009540852A5 (https=)
JP2008508861A5 (https=)
JP2007526759A5 (https=)
CN109709335B (zh) 热休克蛋白hspa4在肿瘤转移预测、预后评估和治疗中的应用
JP2012525121A5 (https=)
CN106701902B (zh) Foxr2基因和表达产物在肝癌诊断与治疗中的应用
CN108003239A (zh) 一种全人源抗egfr单链抗体及其应用
JP2009523004A5 (https=)
CN110305963A (zh) 一种食管癌分子标志物及其应用
US20150212086A1 (en) Diagnosis and Treatment of Brain Tumor
CN110713544A (zh) 融合基因plekha6-ntrk3及其在lch中的应用
JP2007077155A5 (https=)
JP2006104212A5 (https=)
US20160067314A1 (en) Compositions and methods for inhibiting chemoresistance in cancer and improving response to therapy
CN101161283B (zh) CMTM1-v17的新应用及其拮抗剂